July 2025

Bellvitge leads the first clinical trial to evaluate antifibrotic benefit in patients with post-COVID fibrosis

The study confirms the improvement in severe lung affectation after COVID-19 thanks to the combination of pirfenidone and corticosteroids.

Bellvitge leads the first clinical trial to evaluate antifibrotic benefit in patients with post-COVID fibrosis Read More »

Cognitive impairment in lung cancer, an undervalued disorder with new approaches and treatment perspectives

31% of patients already had symptoms of cognitive impairment at the time of lung cancer diagnosis, underscoring the importance of monitoring this disorder to improve patients’ quality of life.

Cognitive impairment in lung cancer, an undervalued disorder with new approaches and treatment perspectives Read More »

Scroll to Top